We have investigated the Kodak Ektachem 400 Analyzer procedure for CO2 for interferences from benzyl alcohol, benzoic acid, and several compounds structurally similar to benzoic acid. Benzoic acid in plasma, at concentrations found in neonates intoxicated with benzyl alcohol, caused a large increase in the results for C02, as did substantially above-normal concentrations of certain fatty acids and ketoacids, and toxic concentrations of aspirin. We observed a correlationbetween increasingbenzoic acid concentrations (up to 17 mmolIL) and falsely increasingCO2 values (>47 liter, as a preservative, were being used to flush umbilical artery catheters and endotracheal tubes in each of these patients. Here we describe the effects of benzyl alcohol, its metabolite benzoic acid, and other compounds similar in structure to benzoic acid on the Ektachem assay for C02, and discuss the influence this interference might have on clinical decisions.
Interferences with Potentiometry of CO2 in the Ektachem 400 Analyzer Mark Steelman,' Carl H. Smith,"2 Aravlndaksha Menon,' Bradley T. Thach,1 Richard E. HIIIman,1 and Michael Landt"2 '3 We have investigated the Kodak Ektachem 400 Analyzer procedure for CO2 for interferences from benzyl alcohol, benzoic acid, and several compounds structurally similar to benzoic acid. Benzoic acid in plasma, at concentrations found in neonates intoxicated with benzyl alcohol, caused a large increase in the results for C02, as did substantially above-normal concentrations of certain fatty acids and ketoacids, and toxic concentrations of aspirin. We observed a correlationbetween increasingbenzoic acid concentrations (up to 17 mmolIL) and falsely increasingCO2 values (>47 mmolIL) obtained with the Ektachem Analyzer for samples from a neonate in the intensive-care unit, who was receiving benzyl alcohol-preserved saline solutions. Although the Ektachem CO2 procedure is simple and rapid, and in most cases accurate, questionable results are occasionally encountered, as indicated by a low anion gap or a measured CO2 exceeding that calculated from blood gas measurements.
Such results require the use of another method for verification.
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Measurement of total carbon dioxide in blood is a valuable tool in evaluating both acid-base status and electrolyte balance. Of the many methods for determining total CO2 concentration, direct potentiometry shows promise of being the most rapid, simple, and accurate (1) (2) (3) (4) . Typically, direct potentiometry involves a liquid-or polymer-membrane electrode that is selective for either carbonate or bicarbonate ions, a reference electrode, and a metering device. In the potentiometric method of the Kodak Ektachem 400 Analyzer, disposable electrode pairs contained on small multilayer slides are hydrated with 10 j.L of the patient's plasma on one side and 10 L of reference solution on the other side; the difference in potential is determined by an electrometer in the analyzer and related through standards to the total CO2 concentration. liter, as a preservative, were being used to flush umbilical artery catheters and endotracheal tubes in each of these patients. Here we describe the effects of benzyl alcohol, its metabolite benzoic acid, and other compounds similar in structure to benzoic acid on the Ektachem assay for C02, and discuss the influence this interference might have on clinical decisions.
Materials and Methods
For the direct potentiometry of CO2 we used the Ektachem 400 Analyzer (Eastman Kodak Co., Rochester, NY 14650) and Ektachem Clinical Chemistry Slides (CO2) according to the manufacturer's specifications.
Each dry, multilayered CO2 slide contains two identical electrodes, such that a complete concentration cell is formed when 10 L of sample fluid is deposited onto one electrode and 10 L of reference fluid is deposited onto the other electrode. Each electrode has a buffer layer (pH 8.4); an ion-selective membrane layer, which is an ion-exchange system consisting of trioctylpropylammonium chlorideand membrane solvents in a vinyl resin; a reference layer of sodium chloride and potassium chloride in gelatin; a silver chloride layer; and a silver layer. The analyzer measures the difference in potential between the reference and sample electrodes in response to the activity of carbonate ions, which is proportional to the total CO2 in the sample (Eastman Kodak Co. Operator's
Manual).
We also used a Beckman Chloride/Carbon Dioxide Analyzer (Beckman Instruments Inc., Fullerton, CA 92634), which measures the rate of change in pH as carbon dioxide is liberated from the sample-which in turn is directly proportional to the total CO2 concentration in the sample.
The compounds evaluated for possible interference (obtained from either Sigma Chemical Co., St. Louis, MO 63178, or United States Biochemical Corp., Cleveland, OH 44122) were prepared as concentrated solutions in either deionized water or Tris HC1 buffer (1 mol!L, pH 8.4). We added various amounts of these solutions to pooled plasma, keeping the final sample volume constant by adding water or buffer as appropriate.
Patients' samples, collected from heel punctures into capillary tubes containing lithium heparin as anticoagulant, or by vempuncture with syringes, were temporarily stored/handled at room temperature for as long as 24 h, then stored frozen in capped 12 x 75 mm conical-bottom plastic tubes for further analysis, if necessary. We assayed samples for CO2 by both methods within 15 mm of each other to minimize losses of CO2 between analyses.
We measured benzoic acid in plasma by gas chromatography as previously described (5) by a method similar to those used in other laboratories (6) .
Results

Erroneous
CO2 values for patients' plasma. on days 6 to 8, when the benzyl alcohol intake was about 150 mg/kg of body weight per day. On day 8, the use of solutions with benzyl alcohol was discontinued, whereupon the difference between the Ektachem and Beckman CO2 values decreased rapidly and disappeared by day 12. Although the patient improved clinically after the use of benzyl alcohol-preserved saline was discontinued, he died later of severe pulmonary interstitial emphysema. In three other patients, similar discrepancies were noted. These discrepancies also became negligible after use of benzyl alcohol-preserved saline was discontinued. Effects of benzyl akohol and benzoic acid. Benzyl alcohol added to pooled plasma at several concentrations had only small effects on results with the Ektachem Analyzer and no effect on those by the Beckman Analyzer (data not shown). Using standard gas-liquid chromatographic techniques, we assayed plasma from the neonate described above for benzoic acid. On day 6, before use of benzyl alcohol was discontinued (Figure 1) , his plasma contained 17 mmol of benzoic acid per liter, and the discrepancy in CO2 values measured with the two analyzers exceeded 47 mmol/L. By about two and one-half days later, the benzoic acid concentration decreased to 3.5 mmolfL, and the total CO2 discrepancy had correspondingly decreased to 8 mmollL. These results are consistent with the data shown in Figure 2; i.e., the concentrations of benzoic acid measured in the patient's plasma were sufficient to falsely increase the Ektachem Analyzer The benzoic acid caused a proportional error (approximately 34% at this concentration of benzoic acid) rather than a set bias (Figure 3) . Buffered solutions (pH 8.4) produced the same type of interference as unbuffered sohtions, confirming that the interference appeared to be CO2 dependent rather than pH dependent. Furthermore, benzoic acid in water did not produce a false reading for CO2 until the benzoic acid concentration exceeded 10 mmol/L, iidicating that the interferente was not due to a direct reaction of benzoic acid with the electrode.
Effects of other compounds.
Because compounds that are structurally similar to benzoic acid may reach high concentrations in plasma in certain pathological states, we tested a series of related compounds for interference with total CO2 determinations with the Ektachem Analyzer. At a concentration of 12 mmol/L, phenylacetic acid, benzenesulfonic acid, and cyclohexanecarboxylic acid each caused an increase in total CO2 of at least 45 mmol/L, similar to the increase caused by benzoic acid (Figure 4) . Benzamide, however, in concentrations as high as 16 mmol/'L did not interfere with the Ektachem CO2 assay.
Because concentrations of short-chain fatty acids may increase in certain disease states, we tested some for interference. Of those we tested, caproic acid caused the greatest interference (35 mmol/L increase in measured CO2 at a caproic acid concentration of 10 mmol/L, as compared with an increase in apparent CO2 of more than 48 mmolfL with benzoic acid in 10 mmol!L), whereas butyric and capric acid in concentrations up to 16 mmollL had little effect on the Ektachem CO2 value (data not shown).
We also investigated the effects of six compounds found in normal plasma that are increased in certain disease states ( Figure 5) . a-Ketoisocaproic acid and a-keto-f3-methyl-nvaleric acid caused a large positive interference in the Ektachem CO2 assay, 10 mmolJL of either acid producing an apparent CO2 increase of about 50 mmol!L. f3-Phenylpyruvate had a small effect, increasing the Ektachem CO2 value by 20 mmolJL at a concentration of 16.5 mniollL. The effects of leucine, f3-hydroxybutyrate, and acetoacetate were negligible at concentrations up to 16.5 mmol/L.
Aspirin, valproic acid, and drugs taken by the affected neonates were studied for possible interference.
Acetylsalicylic acid, 10 mmol/L, increased the Ektachem CO2 value by 24 mmolJL, whereas 50% greater concentrations of salicylic acid or valproic acid were needed to produce the same CO2 increase. Spironolactone, hydrochlorothiazide, sulfathiazole, sulfisoxazole, and "Poly-vi-sol" multivitainin preparation, in 
Discussion
Benzyl alcohol is commonly used as a preservative in saline solutions and in liquid-form medications. Several papers have discussed the toxicity of benzyl alcohol in neonates (7-9). The high concentrations of benzyl alcohol and its metabolite benzoic acid found in plasma from premature neonates were probably from the large dose, in relation to body weight, of benzyl alcohol contained in the "dead volume" of external catheters and to the inability of the immature liver to convert benzoic acid into hippuric acid. Benzoic acid concentrations in serum of premature neonates reportedly can reach 28.7 mmol/L (8). Benzoic acid concentrations of this magnitude in patient sera would falsely increase measured CO2 to values exceeding 65 minollL on the Ektachem Analyzer.
Our limited study of the nature of the benzoic acid interference indicated that (a) the action of benzoic acid required the presence of C02, there being much less interference from benzoic acid in water alone; (b) the error in the measured CO2 was a proportional error; and (c) the interference did not involve changes in pH (which would shift a greater proportion of total CO2 to the carbonate form), shown by similar increases in CO2 by benzoic acid in the presence or absence of strong buffers. The selective membrane in the CO2 electrode of the Ektachem Analyzer, which is similar to those used by others (1,2,4) , is an ion-exchange system consisting of trioctylpropylammonium chloride and membrane solvents in a vinyl resin (Eastman Kodak Co. Operator's Manual). A reasonable rationale to explain the observed interference is that benzoic acid increases the permeability/reactivity of the selective membrane of the CO2 electrode. If so, then benzoic acid would be expected to affect any CO2 electrode based on similar technology.
The normal concentrations of fatty acids in plasma range from 0.3 to 1.1 mmolJL (10). Although several factors can cause concentrations of fatty acids to increase, rarely will their concentrations be high enough (>7 mmol/L) significantly to affect the Ektachem Analyzer value for CO2. Thus, interference by fatty acids is unlikely.
a-Ketoisocaproic acid and a-keto-/3-methyl-n-valeric acid did not interfere with the Ektachem Analyzer CO2 assay within their normal ranges (mean ± SD: 0.03 ± 0.014 and 0.009 ± 0.008 mmol/L, respectively) (11). However, increases in keto acids (to as much as 200-fold the normal value) can occur in cases of maple syrup urine disease; one affected individual had a-ketoisocaproic acid increased to 4.6 mmoIJL and a-keto-/3-methyl-n-valeric acid increased to 1.5 mmolJL (11) . Combined, such concentrations would have falsely increased the apparent CO2 as measured with the Ektachem Analyzer by about 15 mmolfL. Therapeutic concentrations of salicylic acid (<2.2 mmolJL) do not interfere with the Ektachem Analyzer CO2 assay in either of its commonly used forms, acetylsalicylic acid or salicylic acid. However, toxic concentrations are sufficient to interfere. A reported salicylate concentration of 1030 mg/L (7.5 mmolJL) (12) would increase the Ektachem Analyzer CO2 value by 3 mmol/L. Although aspirin is rapidly converted to salicylic acid, approximately 30% remains as acetylsalicylic acid about 20 mm after ingestion (13) . Any acetylsalicylic acid still present in plasma would affect the Ektachem Analyzer CO2 results even more, it being a more potent interferent than salicylic acid.
The valproic acid concentration needed to interfere significantly with the Ektachem Analyzer result for CO2 was about 12 mmol/L, far in excess of its therapeutic range in serum (0.35 to 0.70 mmol/L). Thus valproic acid is unlikely to affect the Ektachem Analyzer CO2 assay.
In 1982 the Food and Drug Administration urged all hospitals and pediatricians to discontinue the use of benzyl alcohol-preserved saline in treating premature infants (14) . Since then, we have encountered many fewer samples with discrepancies between total CO2 values by the Ektachem and the Beckman Analyzers. Benzyl alcohol-preserved saline continues in widespread use with older patients in most hospitals, and users of direct potentiometric methods for CO2 should be aware of the potential for falsely increased CO2 values. Moreover, accidental or uninformed use of benzyl alcohol-preserved saline in neonates may occur. The Ektachem Analyzer method for CO2 appears to be susceptible to interference by other compounds in patients' fluids, but only at concentrations rarely encountered. However, accurate CO2 values are important in several of the conditions in which these potentially interfering concentrations may arise (e.g., salicylate toxicity, maple syrup urine disease).
We routinely use the Ektachem Analyzer for CO2 measurement in our laboratory.
In nearly all instances, the values correlate well with those obtained with other instrumentation and are undoubtedly correct. However, given the documented occurrence of benzoic acid interference and the fact that we continue to observe occasional though rare instances of interference from other (unknown) causes, we believe that users of the Ektachem Analyzer should be alert to the possibility of interference in particular individual patients. A low anion gap or a measured CO2 greater than that calculated from blood-gas measurements will especially suggest this possibility. In any suspicious instance the Ektachem value for CO2 should be confirmed by another method.
Note added in proof:
We have been informed by Eastman Kodak Co. that new Ektachem CO2 slides being developed will include an increased concentration of a scavenger of carboxylic acids. In their preliminary experiments, Eastman KOdak reports substantially less interference from benzoic acid and acetylsalicylic acid.
